Argatroban at 350 microg/kg bolus and 25 microg/kg/min infusion provides adequate anticoagulation for PTCA/stenting, which can be effectively monitored using ACT, HMT, or ECT.
No takes yet. Share an insight, caveat, or question.
Comparable ACT/HMT/ECT readings support interchangeable argatroban monitoring in PTCA; leaves open randomized outcome validation.
Iqbal et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: